The government is expecting two vaccines against Covid-19 — Oxford-AstraZeneca’s Covishield and Bharat Biotech’s Covaxin — to be available by January and around four vaccines by the end of April, increasing the prospects of adequate supplies to inoculate some 30 crore priority populationThe government is expecting two vaccines against Covid-19 — Oxford-AstraZeneca’s Covishield and Bharat Biotech’s Covaxin — to be available by January and around four vaccines by the end of April, increasing the prospects of adequate supplies to inoculate some 30 crore priority populationRead More